angiotensin ii, des-phe(8)- has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 2 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) | Trials (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) | Recent Studies (post-2010) (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 3,412 | 41 | 631 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, EQ; Li, ZC; Liu, ML; Wang, YX; Zhang, B | 1 |
| Bartelmez, SH; Cassis, LA; Jarajapu, YP; Joshi, S; Thatcher, SE; Vasam, G | 1 |
2 other study(ies) available for angiotensin ii, des-phe(8)- and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
| Article | Year |
|---|---|
Fasudil alleviated hypoxia-induced pulmonary hypertension by stabilizing the expression of angiotensin-(1-7) in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin I; Animals; Gene Expression; Hypertension, Pulmonary; Hypoxia; Peptide Fragments; Rats; Rats, Sprague-Dawley; Signal Transduction | 2016 |
Reversal of Bone Marrow Mobilopathy and Enhanced Vascular Repair by Angiotensin-(1-7) in Diabetes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin I; Animals; Blood Vessels; Bone Marrow; Bone Marrow Cells; Cell Lineage; Cell Movement; Chemokine CXCL12; Diabetes Mellitus, Experimental; Ischemia; Male; Membrane Proteins; Mice; Neovascularization, Physiologic; Peptide Fragments; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Recovery of Function; Regeneration; rho-Associated Kinases; Stem Cells; Vascular Endothelial Growth Factor A; Vasodilator Agents | 2017 |